How one pharma insider sees the drug pricing reform law; How states can act to limit drug price increases, saving employers and workers billions

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: How one pharma insider sees the drug pricing reform law: the impact will 'vary by product and by company' By Ed Silverman Charlie Neibergall/AP "At the end of the day, it’s a competitive market and you’ll still price as you would have," says former Gilead executive Jim Meyers. Read More STAT+: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries By Ed Silverman FABRICE COFFRINI/AFP/Getty Images The deal with the Medicines Patent Pool marks the first time that a voluntary licensing deal has been arranged for a cancer medication. Read More Sponsored Insight by VendorFest Cambridge Register at no-cost for VendorFest Cambridge, 10/27 at the Le Meridien Boston/Cambridge Join over 500 drug discovery and development professionals at VendorFest Cambridge, October 27th at the Le Meridien Boston-Cambridge Hotel. Come network with your industry peers, see new products and services from leading vendors serving the biopharma industry, and enjoy our Oktoberfest themed event. Register for this no-cost event. Opinion: How states can act to limit drug price increases, saving employers and workers billions By Sean Dickson Adobe Beyond the Medicare penalty, federal or state action could make it more costly for drugmakers to raise prices above the inflation rate. Read More 'Front of the line': For Alzheimer's patients in successful trial, a feeling of gratitude By Andrew Joseph Adobe Even if lecanumab can slow progression of Alzheimer's by only a little, patients say it could mean a lot for them. Read More Thursday, October 20, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser